The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (guadecitabine), in children and adults with wild type GIST, pheochromocytoma and paraganglioma associated with succinate dehydrogenase deficiency and HLRCC-associated kidney cancer.
 
Jaydira Del Rivero
No Relationships to Disclose
 
Fernanda Irene Arnaldez
Employment - Novartis
Stock and Other Ownership Interests - Kite, a Gilead company
 
Ramaprasad Srinivasan
Research Funding - A2 Technologies; Calithera Biosciences (Inst); Genentech; Genzyme; Novartis; Peloton Therapeutics
 
Melissa Spencer
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Karel Pacak
No Relationships to Disclose
 
Keith Killian
No Relationships to Disclose
 
Lee J. Helman
Employment - MedImmune (I)
 
Paul S. Meltzer
Research Funding - Genzyme (Inst)
 
W. Marston Linehan
No Relationships to Disclose
 
Brigitte C. Widemann
No Relationships to Disclose
 
John Glod
Research Funding - Adaptimmune